Talking transfer RNA for cancer and the biotech ecosystem for startups with Cloverleaf Bio's Austin Draycott

blonca9
Apr 25, 2024
1 min read

He describes how Cloverleaf believes it is different from other tRNA companies and how it has already at the earliest stages benefitted from support of the biotech community.

Recent Posts

See All

As federal funding for cancer research has been jeopardized at NIH and academia, Parker Institute for Cancer Immunotherapy is one private institution ready to step up and broaden its impact

Mount Sinai has embraced AI as a drug discovery tool by launching this month its new AI Small Molecule Drug Discovery Center - Professor Avner Schlessinger tells us why

Jones Healthcare & Technology Innovation Conference: Jones Research analysts Soumit Roy and Justin Walsh share their take on biotech and comment on companies they cover

Talking transfer RNA for cancer and the biotech ecosystem for startups with Cloverleaf Bio's Austin Draycott

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight